Ignacio Sanz

Nov 28, 2024 | cell.com | Caterina E. Faliti |Jinyong Choi |Simon Belanger |Christopher M. Tipton |Sakeenah L. Hicks |Maria Cardenas | +17 more

KeywordsantibodiesvaccineCD4 T cellsT follicular helper cellsTfh cellsplasma cellsIL-2 cytokinemTORmetabolismGet full text accessLog in, subscribe or purchase for full access. References1. Radbruch, A. ∙ Muehlinghaus, G. ∙ Luger, E.O. ... Competence and competition: the challenge of becoming a long-lived plasma cellNat. Rev. Immunol. 2006; 6:741-7502. Slifka, M.K. ∙ Antia, R. ∙ Whitmire, J.K. ... Humoral immunity due to long-lived plasma cellsImmunity. 1998; 8:363-3723.

Sep 27, 2024 | nature.com | Doan C. Nguyen |Natalie Haddad |Pedro A Lamothe |Ignacio Sanz

AbstractSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines are effective at protecting from severe disease, but the protective antibodies wane rapidly even though SARS-CoV-2-specific plasma cells can be found in the bone marrow (BM).

Feb 29, 2024 | dialnet.unirioja.es | Ignacio Sanz

IdiomacatalàDeutschEnglishespañoleuskarafrançaisgalegoitalianoportuguêsromână

Feb 29, 2024 | dialnet.unirioja.es | Ignacio Sanz

IdiomacatalàDeutschEnglishespañoleuskarafrançaisgalegoitalianoportuguêsromână

Feb 28, 2024 | dialnet.unirioja.es | Ignacio Sanz

IdiomacatalàDeutschEnglishespañoleuskarafrançaisgalegoitalianoportuguêsromână